FIELD: medicine.
SUBSTANCE: what is offered is application of idebenone for preparing a drug for transmucosal introductions for treating mitochondral, neurological and neuromotor diseases, and the drug is introduced through a nasal mucosa, an oral mucosa or a colon mucosa.
EFFECT: composition for transmucosal introduction enables to avoid a considerable first-pass metabolism of idebenone, to provide introduction in a lower dose, reduced risk of side effects and higher compliance.
8 cl, 2 dwg, 7 tbl, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| TRANSMUCOSAL INTRODUCTING SYSTEM OF PHARMACEUTICAL DRUG | 2013 |
|
RU2639369C2 |
| FORMULATION FOR MUCOUS MEMBRANE OF ORAL CAVITY AND METHOD OF ITS CALCULATION | 2003 |
|
RU2336875C2 |
| COMPOSITIONS IN THE FORM OF A SPRAY FOR ORAL ADMINISTRATION AND METHODS OF THE SILDENAFIL ADMINISTRATION | 2012 |
|
RU2611403C1 |
| NEW COMPOSITIONS AND METHODS | 2018 |
|
RU2767410C2 |
| PHARMACEUTICAL COMPOSITION AND METHODS FOR USE | 2017 |
|
RU2719450C1 |
| COMPOSITIONS OF GRAPIPRANT AND METHODS FOR USING SAME | 2015 |
|
RU2679631C2 |
| COMPOSITIONS OF GRAPIPRANTE AND METHODS OF THEIR USE | 2015 |
|
RU2811411C2 |
| METHODS OF TREATING FUNGAL INFECTIONS | 2019 |
|
RU2820457C2 |
| COMPOSITIONS FOR DRUG INTRODUCTION | 2009 |
|
RU2554814C2 |
| COMPOSITIONS CONTAINING TRIPTANE COMPOUNDS | 2010 |
|
RU2710372C2 |
